From: Galectin-3 enhances monocyte-derived macrophage efferocytosis of apoptotic granulocytes in asthma
 | EA | NEA | p value |
---|---|---|---|
n | 8 | 7 | Â |
Age, years | 53.7 (±13.0) | 49.7 (±22.0) | 0.672 |
Sex, male (%) | 1 (13) | 2 (29) | 0.438 |
BMI | 33.7 (±4.7) | 28.8 (±3.9) | 0.057 |
Atopy, n (%) | 5 (83) | 3 (60) | 0.387 |
Ex-smoker, n(%) | 3 (38) | 1 (14) | 0.310 |
Pack years | 4.8 (±6.3) | 59.1 | – |
Exhaled CO (ppm) | 4 (3, 7) | 2 (2, 3) | 0.051 |
FEV1 predicted (%) | 84.9 (69.7, 102.3) | 101.9 (82.5, 105.9) | 0.189 |
FEV1/FVC (%) | 92.0 (±16.1) | 97.3 (±15.3) | 0.522 |
Taking ICS, n (%) | 7 (89) | 6 (86) | 0.919 |
ICS dose (μg/day) | 1000 (800, 1000) | 1000 (750, 1625) | 0.422 |
ACQ6 score | 1.3 (0.5, 2.3) | 0.7 (0.2, 0.8) | 0.112 |